Skip to main content

Table 2 Examination and laboratory findings

From: Once versus twice daily antihypertensive medications for the control of nocturnal blood pressure: a comparative study

VariableTotal (n = 199), mean ± SDGroup 1 (n = 135), mean ± SDGroup 2 (n = 64), mean ± SDp value
BMI, Kg/m231.4 ± 6.832.1 ± 7.329.9 ± 5.20.015
 Obesity, no. (%)95 (47.7)69 (51.1)26 (40.6)0.167
Office SBP, mmHg129.0 ± 7.4128.7 ± 7.8129.6 ± 6.60.421
Office DBP, mmHg80.1 ± 5.280.3 ± 5.479.4 ± 4.90.261
Standing SBP, mmHg131.2 ± 9.0130.8 ± 9.3132.1 ± 8.40.342
Standing DBP, mmHg83.9 ± 7.483.3 ± 8.185.2 ± 5.70.055
Heart rate (supine), bpm78.9 ± 8.679.1 ± 8.778.5 ± 8.30.651
Heart rate (standing), bpm83.5 ± 9.484.0 ± 9.282.3 ± 10.00.240
Serum creatinine, mg/dL1.1 ± 0.91.1 ± 1.01.1 ± 0.40.862
Fasting blood glucose, mg/dL102.9 ± 28.2101.7 ± 32.0105.3 ± 18.10.415
Serum cholesterol, mg/dL173.9 ± 31.5176.1 ± 34.4169.4 ± 24.10.179
Serum LDL, mg/dL114.8 ± 25.2116.6 ± 26.8111.2 ± 21.60.183
Serum HDL, mg/dL46.5 ± 8.047.6 ± 7.744.5 ± 8.30.014
Serum TG, mg/dL157.0 ± 35.0156.5 ± 38.6158.1 ± 28.10.768
Serum uric acid, mg/dL5.9 ± 1.45.9 ± 1.45.9 ± 1.50.940
Serum K, mEq/L4.2 ± 0.44.2 ± 0.44.2 ± 0.40.953
Serum Hb, g/L13.3 ± 1.113.3 ± 1.213.2 ± 1.00.665
\